Literature DB >> 16295390

Insulinoma--a case report.

V M Dhume1, A D Amarapurkar, J D Rege, B M Kandalkar, P Varthakavi.   

Abstract

Insulinoma is a rare pancreatic endocrine tumour characterised by hyperinsulinemic hypoglycemia. It is important to surgically remove this tumour as it can cause potentially lethal hypoglycemia. We report a case of insulinoma presenting with unconsciousness following repeated episodes of inability to arise from sleep and convulsions. Biochemical investigation revealed hypoglycemia and hyperinsulinemia. The diagnosis of Insulinoma is often delayed due to misattribution of symptoms to psychiatric or neurological disorders. In this case, same delay lead to fatal outcome for this patient.

Entities:  

Mesh:

Year:  2004        PMID: 16295390

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  5 in total

1.  Insulinoma presenting as idiopathic hypersomnia.

Authors:  Michelangelo Maestri; Fabio Monzani; Enrica Bonanni; Elisa Di Coscio; Fabio Cignoni; Angela Dardano; Alfonso Iudice; Luigi Murri
Journal:  Neurol Sci       Date:  2010-01-30       Impact factor: 3.307

2.  Hypersomnia as the first presentation in a patient with insulinoma: A case report and review of the literature.

Authors:  Jiali Pu; Baorong Zhang; Xinzhen Yin
Journal:  Mol Clin Oncol       Date:  2016-07-27

3.  Insulinoma resembling a rapid eye movement sleep behavior disorder: a case report.

Authors:  Kenji Kishi; Kazutoshi Kubo; Tetsu Tomita; Kazuhiko Nakamura; Norio Yasui-Furukori
Journal:  Int Med Case Rep J       Date:  2019-02-21

4.  Case Report: Insulinoma Presenting as Excessive Daytime Somnolence.

Authors:  Zhennan Yu; Yongliang Wang; Yaqi Sun; Yumei Wang; Yayun Tian; Qinying Ma; Ying Fu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-26       Impact factor: 5.555

5.  Episodic confusional state: Due to insulinoma.

Authors:  Venkatesan Jagadheesan; Stelina Sophie Dina Suresh
Journal:  Indian J Psychiatry       Date:  2008-07       Impact factor: 1.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.